Skip to main content

Year: 2025

Wolters Kluwer 2025 Nine-Month Trading Update

Wolters Kluwer 2025 Nine-Month Trading Update Alphen aan den Rijn, November 5, 2025 – Wolters Kluwer, a global leader in professional information solutions, software and services, today releases its scheduled 2025 nine-month trading update. HighlightsFull-year 2025 guidance reaffirmed. Nine-month revenues up 7% in constant currencies and up 6% organically.Recurring revenues (84% of total revenues) grew 7% organically. Recurring cloud software revenues (21% of total revenues) grew 15% organically. Print revenue decline reduced group organic growth by 50 basis points.Nine-month adjusted operating profit up 15% in constant currencies.Margin increase reflects on-going mix shift and cost efficiencies.Nine-month adjusted free cash flow up 17% in constant currencies.Cash conversion benefitted from favorable timing of working capital...

Continue reading

TME Pharma advances its new investment strategy and signs LOI with German resources company

TME Pharma advances its new investment strategy and signs LOI with German resources companyA further step toward investment diversification into potential cash-flow–generating assets A potential strategic investment in sustainable tailings reprocessing and environmental rehabilitation projects for precious metals with strong value-creation prospects.         Upon successful completion of due diligence, the proposed transaction will be submitted to shareholders at an Extraordinary General Meeting.TME Pharma reaffirms its commitment to advancing its biotech assets, with discussions continuing in parallel with potential partners.Berlin, Germany, November 05, 2025, 08.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye...

Continue reading

Sydbank’s Interim Report – Q1-Q3 2025

Company Announcement No 54/20255 November 2025Sydbank’s Interim Report – Q1-Q3 2025 Sydbank delivers very satisfactory profit                                                                                                                 The first three quarters of the year are characterised by growth in almost all parameters. The Bank has expanded its business without compromising on profitability. It has delivered a return on equity of 17.4% and is also attracting more customers and more satisfied customers from all three segments – corporate, retail and Private Banking – in spite of macroeconomic uncertainty and a general reluctance to invest.There is a lot to be pleased about in the interim financial statements. We are seeing significant activity and we deliver on all our three promises in our strategy Bigger Sydbank. We have generated...

Continue reading

Novo Nordisk’s sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues

Bagsværd, 5 November, 2025 – Financial report for the period 1 January 2025 to 30 September 2025                                                                                                                     Operating profit increased by 5% in Danish kroner and 10% at constant exchange rates (CER) to DKK 95.9 billion, impacted by one-off restructuring costs of around DKK 9 billion related to the company-wide transformation with the aim of streamlining Novo Nordisk’s operations to reinvest for growth. Had Novo Nordisk not incurred such restructuring costs amounting to around DKK 9 billion, operating profit would have increased by 15% in Danish kroner and 21% at CER. Sales in US Operations increased by 12% in Danish kroner (15% at CER). Sales in the US were positively impacted by gross-to-net sales adjustments. Sales in...

Continue reading

Sampo Group’s results for January–September 2025

Sampo plc, Interim Statement, 5 November 2025 at 8:30 am EET Sampo Group’s results for January–September 2025Like-for-like top-line growth stood at 8 per cent as the Group continued to see strong momentum across private and SME lines with an acceleration of growth in Private Nordic. The underwriting result increased by 17 per cent on a currency adjusted basis to EUR 1,121 million, fuelled by solid top-line growth and strong margins. Operating EPS strengthened by 14 per cent on the increase in the underwriting result. To reflect the strong results achieved to date and firm confidence in the Group’s prospects, the Board has decided to increase the operating EPS growth target for 2024-2026 to more than 9 per cent annually on average from more than 7 per cent. Reported EPS increased by 40 per cent, supported by EUR 355 million net gain...

Continue reading

Bouygues: Nine-month 2025 results

NINE-MONTH 2025 RESULTS Paris, 05/11/25 STRONG NINE-MONTH 2025 GROUP RESULTS THE GROUP IS TARGETING, FOR 2025, A SLIGHT INCREASE IN COPA AND A SLIGHT INCREASE IN SALES AT CONSTANT EXCHANGE RATES, VERSUS 2024Group sales: €41.9bn, up 0.9% year-on-year, notably driven by the construction businesses. The Group’s third-quarter 2025 sales were stable year-on-year at €15bn and included exchange rate effects of around -€250m over the third quarter. Group current operating profit from activities (COPA): €1,814m, up €95m year-on-year, an increase driven by the construction businesses and Equans. Net profit attributable to the Group (excluding the exceptional income tax surcharge for large companies in France) amounted to €735m, improving €48m year-on-year. The estimated effects of the French Finance law and the Social security financing law for...

Continue reading

Pandora delivers 6% organic growth in Q3

FINANCIAL HIGHLIGHTS In Q3 2025, Pandora delivered organic revenue growth of 6% despite the turbulent macroeconomic backdrop. The organic growth comprised of like-for-like (LFL) growth of 2% and network expansion etc. of 4%.LFL growth in the US and Rest of Pandora remained robust at 6%. Overall LFL growth in Europe was    -1% with the four European markets disclosed separately weighing on growth and offsetting the solid growth in several other countries, such as Spain, Portugal and Poland.The gross margin remained strong at 79.3% despite 280bp of headwinds from foreign exchange, commodities and tariffs (80.1% in Q3 2024).   The Q3 2025 EBIT margin landed at 14.0% as expected. The margin declined by 210bp Y/Y reflecting a significant 380bp headwind from foreign exchange, commodities and tariffs.Reported EPS growth in Q3 2025 was -14% (+5%...

Continue reading

Report for the nine-month period ended 30 September 2025

HighlightsProportionate power generation amounted to 574 GWh for the reporting period, with additional 30 GWh of compensated volumes from ancillary services and availability warranties, bringing the total proportionate power generation, including these volumes, to 604 GWh. The Company now expects full-year 2025 proportionate power generation, including compensated volumes, to be between 850 and 900 GWh. Completed the sale of a 76 MW solar project in Germany for a total consideration of MEUR 4.0. The transaction closed in July 2025 with MEUR 2.0 paid on closing, leading to a net profit of MEUR 1.1 and with an outstanding MEUR 2.0 contingency payment subject to municipal and legislative approvals. Entered into financial hedges for approximately 200 GWh of the 2026 proportionate power generation volumes in the SE3 and SE4 price areas, at...

Continue reading

Sampo launches a buyback programme of EUR 150 million

Sampo plc, stock exchange release, 5 November 2025 at 8:45 am EET Sampo launches a buyback programme of EUR 150 million In connection with its first half of 2025 results, Sampo indicated that it would return the proceeds from a potential IPO of NOBA Bank Group AB (publ) through a share buyback programme. Consequently, Sampo’s Board of Directors has resolved to launch a new EUR 150 million share buyback programme with the proceeds from the listing of NOBA Bank Group AB (publ) that took place on 26 September 2025. Sampo remains committed to operating with a strong but efficient balance sheet and will review its excess capital position annually with the latest review been conducted in August 2025. The aggregate purchase price of the Sampo A shares acquired under the share buyback programme shall not exceed EUR 150 million and the maximum...

Continue reading

Trading update for 1 January – 30 September 2025

Company Announcement Copenhagen, 5 November 2025No. 62/2025 Trading update for 1 January – 30 September 2025 Robust first nine months with continued business improvements Highlights Financial updateOrganic growth was 4.9% in Q3 2025 (Q3 2024: 4.8%) and 4.3% for the first nine months of 2025 mainly driven by price increases, volume growth and projects and above-base work, partially offset by net negative contract wins. Operating margin and free cash flow developed in line with expectations as a result of continued operational improvements including successfully managing wage and cost inflation by implementing price increases across the Group.Business updateISS secured nine new contracts with large key account customers (annual revenue above DKK 100 million). In addition, 21 contracts were extended, nine with significant scope expansions....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.